Metabolites derived from omega-3 polyunsaturated fatty acids are important for cardioprotection

European Journal of Pharmacology

Volumn 769, Issue , 2015, Pages 147-153

  Gilbert, Kim ^a,b   Malick, Mandy ^a,b   Madingou, Ness ^a,b   Touchette, Charles ^a,b   Bourque Riel, Valérie ^a,b   Tomaro, Leandro ^a,b   Rousseau, Guy ^a,b  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardioprotection; Inhibitors; Metabolites; Myocardial infarction; Omega 3; Resolvin D1

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; CASPASE 3; CASPASE 8; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTECTIVE AGENT; PROTEIN KINASE B; RESOLVIN D1; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; DOCOSAHEXAENOIC ACID; LIPOXYGENASE INHIBITOR; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ADVERSE EFFECTS; ANIMAL; DIET; DOSE RESPONSE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MYOCARDIAL INFARCTION; NEUTROPHIL; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOTONIC AGENTS; CASPASE 3; CASPASE 8; CYCLOOXYGENASE 2 INHIBITORS; DIET; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; LIPOXYGENASE INHIBITORS; MYOCARDIAL INFARCTION; NEUTROPHILS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84948959673     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.11.010     Document Type: Article

References (40)

1. A. Abbate, D. Santini, G.G. Biondi-Zoccai, S. Scarpa, F. Vasaturo, G. Liuzzo, R. Bussani, F. Silvestri, F. Baldi, F. Crea, L.M. Biasucci, and A. Baldi Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe? Heart 90 2004 440 443
2. G.G. Abdukeyum, A.J. Owen, and P.L. McLennan Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning J. Nutr. 138 2008 1902 1909
3. M. Arita, S.F. Oh, T. Chonan, S. Hong, S. Elangovan, Y.P. Sun, J. Uddin, N.A. Petasis, and C.N. Serhan Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions J. Biol. Chem. 281 2006 22847 22854
4. Y. Chen, C. Peng, S.A. Abraham, Y. Shan, Z. Guo, N. Desouza, G. Cheloni, D. Li, T.L. Holyoake, and S. Li Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival J. Clin. Investig. 124 2014 3847 3862
5. M. de Lorgeril, G. Rousseau, A. Basmadjian, G. St-Jean, D.C. Tran, and J.G. Latour Spacial and temporal profiles of neutrophil accumulation in the reperfused ischemic myocardium Am. J. Cardiovasc. Pathol. 3 1990 143 154
6. M. Dona, G. Fredman, J.M. Schwab, N. Chiang, M. Arita, A. Goodarzi, G. Cheng, U.H. von Andrian, and C.N. Serhan Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets Blood 112 2008 848 855
7. X. Dong, R. Li, P. Xiu, X. Dong, Z. Xu, B. Zhai, F. Liu, H. Jiang, X. Sun, J. Li, and H. Qiao Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2-dependent and -independent pathways PLoS One 9 2014 e92864
8. K. Gilbert, J. Bernier, V. Bourque-Riel, M. Malick, and G. Rousseau Resolvin D1 reduces infarct size through a phosphoinositide 3-kinase/protein kinase B mechanism J. Cardiovasc. Pharmacol. 2015 72 79 10.1097/FJC.0000000000000245
9. J.R. Hart, and P.K. Vogt Phosphorylation of AKT: a mutational analysis Oncotarget 2 2011 467 476
10. M.H. Hassan, H.A. El-Beshbishy, H. Aly, S.M. Attia, S.A. Bahashwan, and M.M. Ghobara Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice Cancer Chemother. Pharmacol. 74 2014 559 569
11. S. Hong, K. Gronert, P.R. Devchand, R.L. Moussignac, and C.N. Serhan Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation J. Biol. Chem. 278 2003 14677 14687
12. W.F. Huang, F.Y. Hsiao, Y.W. Tsai, Y.W. Wen, and Y.T. Shih Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study Drug Saf. 29 2006 261 272
13. J. Kajstura, W. Cheng, K. Reiss, W. Clark, E. Sonnenblick, S. Krajewski, J. Reed, G. Olivetti, and P. Anversa Apoptotic and necrotic cell deaths are independent contributing variables of infarct size in rats Lab. Investig. 74 1996 86 107
14. K.T. Keyes, Y. Ye, Y. Lin, C. Zhang, J.R. Perez-Polo, P. Gjorstrup, and Y. Birnbaum Resolvin E1 protects the rat heart against reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 299 2010 H153 H164
15. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
16. L. Lada-Moldovan, S. Kaloustian, T.M. Bah, S.A. Girard, M.A. Dery, and G. Rousseau Chronic pretreatment with celecoxib reduces infarct size J. Cardiovasc. Pharmacol. 54 2009 31 37
17. H. Li, X.Z. Ruan, S.H. Powis, R. Fernando, W.Y. Mon, D.C. Wheeler, J.F. Moorhead, and Z. Varghese EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism Kidney Int. 67 2005 867 874
18. M.K. Middleton, A.M. Zukas, T. Rubinstein, M. Jacob, P. Zhu, L. Zhao, I. Blair, and E. Pure Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease J. Exp. Med. 203 2006 2529 2540
19. K. Nageswari, R. Banerjee, and V.P. Menon Effect of saturated, omega-3 and omega-6 polyunsaturated fatty acids on myocardial infarction J. Nutr. Biochem. 10 1999 338 344
20. B.M. Peskar, K. Ehrlich, R. Schuligoi, and B.A. Peskar Role of lipoxygenases and lipoxin A(4)/annexin-1 receptor in gastric protection induced by 20% ethanol or sodium salicylate in rats Pharmacology 84 2009 310 313
21. E.C. Rizos, E.E. Ntzani, E. Bika, M.S. Kostapanos, and M.S. Elisaf Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis J. Am. Med. Assoc. 308 2012 1024 1033
22. I. Rondeau, S. Picard, T.M. Bah, L. Roy, R. Godbout, and G. Rousseau Effects of different dietary omega-6/3 polyunsaturated fatty acids ratios on infarct size and the limbic system after myocardial infarction Can. J. Physiol. Pharmacol. 89 2011 169 176
23. T. Saito, D. Tamura, and R. Asano Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors Oncol. Rep. 31 2014 1637 1644
24. C. Serhan, S. Hong, K. Gronert, S. Colgan, P. Devchand, G. Mirick, and R. Moussignac Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037
25. C.N. Serhan Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am. J. Pathol. 177 2010 1576 1591
26. C.N. Serhan, M. Arita, S. Hong, and K. Gotlinger Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers Lipids 39 2004 1125 1132
27. C.N. Serhan, and N. Chiang Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus Br. J. Pharmacol. 153 Suppl. 1 2008 S200 S215
28. C.N. Serhan, K. Gotlinger, S. Hong, and M. Arita Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis Prostaglandins Other Lipid Mediat. 73 2004 155 172
29. C.N. Serhan, S. Krishnamoorthy, A. Recchiuti, and N. Chiang Novel anti-inflammatory - pro-resolving mediators and their receptors Curr. Top. Med. Chem. 11 2011 629 647
30. P.J. Simpson, J.C. Fantone, J.K. Mickelson, K.P. Gallagher, and B.R. Lucchesi Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 h of reperfusion Circ. Res. 63 1988 1070 1079
31. P. Singer, H. Shapiro, M. Theilla, R. Anbar, J. Singer, and J. Cohen Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective Intensive Care Med. 34 2008 1580 1592
32. L. Song, H. Yang, H.X. Wang, C. Tian, Y. Liu, X.J. Zeng, E. Gao, Y.M. Kang, J. Du, and H.H. Li Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways Apoptosis 19 2014 567 580
33. L.M. Sordillo, J.A. Weaver, Y.Z. Cao, C. Corl, M.J. Sylte, and I.K. Mullarky Enhanced 15-HPETE production during oxidant stress induces apoptosis of endothelial cells Prostaglandins Other Lipid Mediat. 76 2005 19 34
34. R.I. Sperling The effects of dietary n-3 polyunsaturated fatty acids on neutrophils Proc. Nutr. Soc. 57 1998 527 534
35. Y. Tasaki, T. Omura, T. Yamada, T. Ohkubo, M. Suno, S. Iida, T. Sakaguchi, M. Asari, K. Shimizu, and K. Matsubara Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells Brain Res. 1344 2010 25 33
36. R.H. Tolba, N. Fet, K. Yonezawa, K. Taura, A. Nakajima, K. Hata, Y. Okamura, H. Uchinami, U. Klinge, T. Minor, Y. Yamaoka, and Y. Yamamoto Role of preferential cyclooxygenase-2 inhibition by meloxicam in ischemia/reperfusion injury of the rat liver Eur. Surg. Res. 53 1-4 2014 11 24 10.1159/000362411
37. T. Tran Quang, A.-A. Gosselin, V. Bourque-Riel, K. Gilbert, T. Charron, and G. Rousseau Effect of Resolvin D1 on experimental myocardial infarction Exp. Clin. Cardiol. 20 2014 6704 6712
38. K.H. Weylandt, C.Y. Chiu, B. Gomolka, S.F. Waechter, and B. Wiedenmann Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation Prostaglandins Other Lipid Mediat. 97 2012 73 82
39. J.W. Winkler, J. Uddin, C.N. Serhan, and N.A. Petasis Stereocontrolled total synthesis of the potent anti-inflammatory and pro-resolving lipid mediator resolvin D3 and its aspirin-triggered 17R-epimer Org. Lett. 15 2013 1424 1427
40. Z.Q. Zhao, and J. Vinten-Johansen Postconditioning: reduction of reperfusion-induced injury Cardiovasc. Res. 70 2006 200 211